ArticleChemRxiv : the preprint server for chemistry2020
Shotgun drug repurposing biotechnology to tackle epidemics and pandemics.
William Mangione, Zackary Falls, Thomas Melendy, Gaurav Chopra, Ram Samudrala
Abstract readPreprint
In one paragraphArticle in ChemRxiv : the preprint server for chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
William MangioneDepartment of Biomedical Informatics, University at Buffalo, Buffalo, NY, 14120, United States.
Zackary FallsDepartment of Biomedical Informatics, University at Buffalo, Buffalo, NY, 14120, United States.
Thomas MelendyDepartment of Microbiology and Immunology, University at Buffalo, Buffalo, NY, 14120, United States.
Gaurav ChopraDepartment of Chemistry, Purdue Institute for Drug Discovery, Integrated Data Science Institute, Purdue University, West Lafayette, IN, 47907, United States.
Ram SamudralaDepartment of Biomedical Informatics, University at Buffalo, Buffalo, NY, 14120, United States.
Funding
Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI Douglas Grant Cuttell · 1985 to 2026
$43.4MUniversity of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8MQuality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2MNational Library of Medicine Conference 2022T15LM012495 · NLM · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PETER L. ELKIN · 2017 to 2026
$4.3MNOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENINGDP1LM011509 · NLM · UNIVERSITY OF WASHINGTON · PI SAMUDRALA, RAM · 2012 to 2014
$2.4MNOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENINGDP1OD006779 · OD · UNIVERSITY OF WASHINGTON · PI SAMUDRALA, RAM · 2010 to 2011
$1.7MNCATS NIH HHS UL1 TR001412NCATS NIH HHS UL1 TR002529NCI NIH HHS P30 CA023168NIH HHS DP1 OD006779NLM NIH HHS DP1 LM011509NLM NIH HHS T15 LM012495
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
computationalCOVID-19drug discoverydrug repurposingmultitargetingSARS-CoV-2
Identifiers
PMID32511286
PMCPMC7252447
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390